Article info
PDFPostScript
Letter
One-year outcome of bilateral randomised prospective clinical trial comparing photorefractive keratectomy (PRK) with mitomycin C (MMC) and laser in situ keratomileusis (LASIK)
- Correspondence to Dr Merle Fernandes, LV Prasad Eye Institute, GMRV Campus, Plot 87/2, Hanumanthawaka Junction, Visakhapatnam, Anhdra Pradesh, India; merle{at}lvpei.org
Citation
One-year outcome of bilateral randomised prospective clinical trial comparing photorefractive keratectomy (PRK) with mitomycin C (MMC) and laser in situ keratomileusis (LASIK)
Publication history
- Accepted May 27, 2010
- First published August 23, 2010.
Online issue publication
March 22, 2016
Article Versions
- Previous version (22 March 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.